At Hemophilia Outreach Center, we’re committed to more than just medicine — we’re committed to people. Gene therapy is a groundbreaking treatment, but what makes it truly meaningful are the people behind it — the patients who face each day with courage, the care teams who prepare with precision, and the leaders who ensure every individual feels seen, heard, and supported.
In this video series, we’re bringing together the voices of patients and staff — including our CEO, who shares his personal connection to hemophilia B — to tell the story of how gene therapy for hemophilia is changing lives and how HOC continues to be a trusted partner in care, education, and innovation.
When HOC’s CEO, Jamison Buxton, reflects on his journey with Hemophilia Outreach Center, it starts with a deeply personal story — the birth of his son, who was diagnosed with hemophilia B. Like many parents facing a rare diagnosis for the first time, Jamison was overwhelmed with questions, fears, and the uncertainty of what life would look like moving forward. But it was during those early years — through late-night calls, emergency room visits, and countless infusions — that he came to understand the full value of having a trusted treatment center by your side.
That experience didn’t just shape him as a parent. It became the foundation for how he would later lead the very organization that once helped guide him. Today, as CEO, Jamison brings that same level of empathy, advocacy, and determination to every patient HOC serves.
“There were some incredible people here that helped not only raise him, but they raised me as well in growing up with a child with a bleeding disorder.”
— Jamison Buxton, CEO
Jamison’s story speaks to the heart of what HOC stands for: a commitment to building lifelong relationships, supporting families through every stage of care, and delivering a level of service that goes far beyond clinical treatment. It’s about walking the path together — not just in moments of crisis, but every step of the way.
At HOC, patient care is never transactional. It’s collaborative, built on trust and open communication. Our team believes in treating the whole person, recognizing that bleeding disorders impact not just physical health but emotional well-being, family dynamics, and everyday life. That’s why our model of care is both comprehensive and personalized — designed to meet each patient where they are, with compassion and clarity.
“Patient advocacy is very important to us. It really helps drive what patients need, what patients want, and allows us to create a direction for how patients want to be served.”
— Jamison Buxton, CEO
Advocacy is woven into everything we do. For us, it means being proactive, informed, and deeply invested in the lives of the people we serve. It means educating patients about their options — including emerging treatments like gene therapy — and walking alongside them as they consider what’s right for their unique needs and goals. It means showing up — consistently, respectfully, and with purpose.
As Jamison puts it, the goal isn’t to simply treat a condition. It’s to empower patients and families to live fully, confidently, and with the knowledge that they are never alone in their journey.
Looking Ahead Together
Gene therapy for hemophilia represents a new chapter in bleeding disorder care — and HOC is proud to be part of that progress. But even more than that, we’re proud to support our patients with the same level of commitment we always have: personalized, compassionate, full-spectrum care.
Our approach doesn’t change with new treatments — it evolves. We remain focused on education, partnership, and walking alongside each individual on their unique path.
English
Afsoomaali
Español